Science and Technology

Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action

By Harshit CAMBRIDGE, MASSACHUSETTS, NOV. 30 —For decades, scientists viewed vision as a primarily bottom-up process: light hits the retina, signals travel to the visual cortex, and the brain forms an image. New research from MIT’s Picower Institute, published in Neuron, fundamentally challenges this model, showing the relationship is a two-way street. The study, led by senior author Professor Mriganka…

Exterior view of MIT’s Picower Institute, where the visual perception study was conducted.

Editorial picks

Exterior view of MIT’s Picower Institute, where the visual perception study was conducted.
Science and Technology

Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action

By Harshit CAMBRIDGE, MASSACHUSETTS, NOV. 30 —For decades, scientists viewed vision as a primarily bottom-up process: light hits the retina, signals travel to the visual cortex, and the brain forms an image. New research from MIT’s Picower Institute, published in Neuron, fundamentally challenges this model, showing the relationship is a…

Around The World

Health

Pharmacogenomic Testing Validation: Is the FDA Table of Associations Sufficient for US Clinicians?

BY Harshit, 30 NOV 2025 This high-E-E-A-T article is tailored for the US clinical and health-tech audience. It focuses on the critical gap between FDA regulatory labeling and comprehensive clinical practice guidelines, a point of confusion that attracts highly informed, commercially valuable traffic. Pharmacogenomic (PGx) testing promises to end the “trial-and-error” prescribing common in US medicine—particularly for complex conditions like…

Illustration comparing FDA pharmacogenomic tables with CPIC clinical guidelines used in US healthcare decision-making

Stay Connected

Subscribe